Validation of the anticholinergic medication index prediction model (ACMI-PM) for use in secondary care settings, CY P03 25 01

Lay Summary

One in four older adults admitted to hospital are taking medication with an anticholinergic effect, known as anticholinergic medication. Anticholinergic medication have been linked with a higher chance of confusion and suffering a fall. The anticholinergic medication index prediction model is a clinical tool which calculates a person’s risk of experiencing confusion or a fall whilst living in the community, based on their medical history and the anticholinergic medication they are taking. This tool has been developed using anonymised patient data from general practices. The aim of this project is to see if the ACMI-PM can accurately calculate a person’s risk of developing delirium or suffering a fall during a hospital stay. If this is the case, it could be used to identify those at higher risk. These people could then be prioritised for a review of their medication which may result stopping or pausing any anticholinergic medication.

Trading name

Connected Bradford

Legal name of contracting organisation

Bradford Teaching Hospitals Foundation TRUST (BTHFT)

Website link to find more information

Date of counter-signed DAA/DSA

10/04/2025

Period of DAA

2 years

Privacy

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

For more information, please visit our Privacy Policy.